ResearcherTohoku UniversityNo recent work listed

Katsuya Fukui

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper

Papers 1

PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. Co-author DOI 10.1111/cas.15315 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ikuro Sato · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗
Hiroyuki Kato · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗
Keiichi Jingu · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗
Keiichi Tamai · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗
Hiroshi Shima · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗
Kennichi Satoh · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗
Toru Furukawa · 1 shared paper, 2022 · strength 0.12
- Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.